Daily Walks Near Traffic Pollution Increased COPD Cough, Sputum
Traffic-related air pollution can worsen respiratory symptoms during daily exercise for people with chronic lung disease.
Traffic-related air pollution can worsen respiratory symptoms during daily exercise for people with chronic lung disease.
Traffic-related air pollution can worsen respiratory symptoms during daily exercise for people with chronic lung disease.
Read MoreNew research suggests acoustic speech features can identify respiratory exacerbations from the first day of onset.
Read MoreAmerican Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.
Read MoreGrifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.
Read MoreNew research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
Read MoreENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
Read MoreResearchers suggest delivering vitamin D directly to the lungs could bypass the limitations of oral supplements in treating COPD and asthma.
Read MoreAERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.
Read MorePatients with pneumonia or COPD faced higher mortality risks and readmission at facilities owned by private equity firms, according to new research.
Read MoreA newly discovered biological process protects liver cells from protein buildup in patients with alpha-1-antitrypsin deficiency.
Read MoreThe COPD-OMA trial will examine if the asthma drug omalizumab (Xolair) benefits COPD patients with sensitivities to indoor allergens.
Read MoreThe initiative focuses on integrating respiratory services into primary healthcare to improve diagnosis and treatment access.
Read MoreThe MIRANDA study found tozorakimab significantly lowered the rate of moderate-to-severe respiratory worsening in patients regardless of smoking history or specific white blood cell counts.
Read MoreNew research suggests isoflavones found in plant-based foods like soy and legumes can reduce inflammation and coughing for patients with COPD.
Read MoreA study of Medicare Advantage beneficiaries with COPD shows that pharmacist-led telephone education significantly reduces errors in medication delivery.
Read MoreA new whitepaper shows that real-time clinical insights for primary care physicians led to higher flu vaccination rates and fewer emergency visits for high-risk populations, including COPD patients.
Read MorePhase 1 study revealed significant FEV1 improvements within 15 min of a single dose of IV rademikibart — an antibody targeting interleukin-4 receptor alpha.
Read MoreThe monoclonal antibody Tozorakimab showed significant clinical benefit in reducing COPD flare-ups for a broad range of patients, including former and current smokers.
Read MoreSleep metrics from wrist monitors can identify which COPD patients may need more support during pulmonary rehab.
Read MoreNon-pharmacological strategies like breathing techniques and positioning help COPD patients manage acute episodes and improve confidence.
Read MoreAffordability and education are preventing COPD patients from remaining adherent to their prescribed pharmacologies.
Read MoreCertain neighborhood characteristics, including higher poverty, more uninsured residents, and lower educational attainment, may lead to an increase in COPD-related emergency department visits and hospitalizations.
Read MoreAdults who obtained 10% or more of their daily calories from sugary drinks had a 39% higher likelihood of having COPD compared with those consuming <10%.
Read MoreDry powder and soft mist inhalers—which have a lower carbon footprint than metered-dose inhalers (MDIs)—were associated with slightly better clinical outcomes for COPD patients.
Read More